Probi AB

Probi AB is a pioneering company dedicated to researching, manufacturing, and delivering probiotics for supplements and functional food. Founded in 1991 at Sweden’s Lund University, the company has expanded its operations to more than 40 markets and holds more than 400 patents globally. Probi is a recognized expert in managing stable, live bacteria from R&D through every stage of the manufacturing process and is committed to making the health-enhancing benefits of probiotics available worldwide. The company's health concepts, formulations, and formats are backed by robust clinical documentation. Probi operates within the industries of agriculture, biotechnology, food and beverage, and healthcare. As a venture capital investor, Probi AB represents an intriguing opportunity within the burgeoning probiotics market. The company's focus on research and development aligns with the increasing demand for health and wellness products, particularly those that boast robust clinical documentation. Probi's global expansion and extensive patent portfolio signal a commitment to innovation and a strong foothold in multiple markets. Furthermore, the company's roots in academia at Lund University speak to a foundation of rigorous scientific inquiry. Probi's dedication to making the benefits of probiotics accessible to a wide audience represents a compelling investment prospect in the health and wellness sector.